{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,12]],"date-time":"2024-08-12T05:06:43Z","timestamp":1723439203545},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,8]]},"DOI":"10.7759\/cureus.59933","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:38:56Z","timestamp":1715233136000},"source":"Crossref","is-referenced-by-count":1,"title":["Risk Assessment of Critical Obstetric Bleeding With Low-Molecular-Weight Heparin"],"prefix":"10.7759","author":[{"given":"Miho","family":"Akaishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasumi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Akaishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fujimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Yaegashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S273047","article-title":"DIC in pregnancy - pathophysiology, clinical characteristics, diagnostic scores, and treatments","volume":"13","author":"Erez O","year":"2022","unstructured":"Erez O, Othman M, Rabinovich A, Leron E, Gotsch F, Thachil J. DIC in pregnancy - pathophysiology, clinical characteristics, diagnostic scores, and treatments. J Blood Med. 2022, 13:21-44. 10.2147\/JBM.S273047","journal-title":"J Blood Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000001110","article-title":"Disseminated intravascular coagulation syndromes in obstetrics","volume":"126","author":"Cunningham FG","year":"2015","unstructured":"Cunningham FG, Nelson DB. Disseminated intravascular coagulation syndromes in obstetrics. Obstet Gynecol. 2015, 126:999-1011. 10.1097\/AOG.0000000000001110","journal-title":"Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1481029","article-title":"Maternal mortality due to hemorrhage: Population-based study in Turkey","volume":"32","author":"Gulumser C","year":"2019","unstructured":"Gulumser C, Engin-Ustun Y, Keskin L, et al.. Maternal mortality due to hemorrhage: Population-based study in Turkey. J Matern Fetal Neonatal Med. 2019, 32:3998-4004. 10.1080\/14767058.2018.1481029","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000564","article-title":"Pregnancy-related mortality in the United States, 2006-2010","volume":"125","author":"Creanga AA","year":"2015","unstructured":"Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol. 2015, 125:5-12. 10.1097\/AOG.0000000000000564","journal-title":"Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jog.14875","article-title":"Capacity of Japanese institutions to manage obstetrical disseminated intravascular coagulation in 2018: A national surveillance questionnaire and retrospective cohort study","volume":"47","author":"Morikawa M","year":"2021","unstructured":"Morikawa M, Nii M, Nakabayashi Y, Itakura A, Kobayashi T, Adachi T. Capacity of Japanese institutions to manage obstetrical disseminated intravascular coagulation in 2018: A national surveillance questionnaire and retrospective cohort study. J Obstet Gynaecol Res. 2021, 47:3159-70. 10.1111\/jog.14875","journal-title":"J Obstet Gynaecol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-021-03119-5","article-title":"Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: A multicenter retrospective cohort study","volume":"114","author":"Morikawa M","year":"2021","unstructured":"Morikawa M, Matsunaga S, Makino S, et al.. Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: A multicenter retrospective cohort study. Int J Hematol. 2021, 114:18-34. 10.1007\/s12185-021-03119-5","journal-title":"Int J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2010.01319.x","article-title":"Maternal death analysis from the Japanese autopsy registry for recent 16 years: Significance of amniotic fluid embolism","volume":"37","author":"Kanayama N","year":"2011","unstructured":"Kanayama N, Inori J, Ishibashi-Ueda H, et al.. Maternal death analysis from the Japanese autopsy registry for recent 16 years: Significance of amniotic fluid embolism. J Obstet Gynaecol Res. 2011, 37:58-63. 10.1111\/j.1447-0756.2010.01319.x","journal-title":"J Obstet Gynaecol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2014.01016","article-title":"Amniotic fluid embolism (AFE) in China: Are maternal mortality and morbidity preventable?","volume":"3","author":"Mo X","year":"2014","unstructured":"Mo X, Feng A, Liu X, Tobe RG. Amniotic fluid embolism (AFE) in China: Are maternal mortality and morbidity preventable?. Intractable Rare Dis Res. 2014, 3:97-9. 10.5582\/irdr.2014.01016","journal-title":"Intractable Rare Dis Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2015.1108403","article-title":"Evaluation of obstetrical patients with disseminated intravascular coagulopathy - tertiary center experience","volume":"29","author":"Ba\u015farano\u011flu S","year":"2016","unstructured":"Ba\u015farano\u011flu S, S\u0131dd\u0131k Evsen M, A\u011fa\u00e7ayak E, et al.. Evaluation of obstetrical patients with disseminated intravascular coagulopathy - tertiary center experience. J Matern Fetal Neonatal Med. 2016, 29:2929-33. 10.3109\/14767058.2015.1108403","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30687-0","article-title":"Impact of fetal maceration grade on risk of maternal disseminated intravascular coagulation after intrauterine fetal death - A retrospective cohort study","volume":"8","author":"Muin DA","year":"2018","unstructured":"Muin DA, Haslacher H, Koller V, Kiss H, Scharrer A, Farr A. Impact of fetal maceration grade on risk of maternal disseminated intravascular coagulation after intrauterine fetal death - A retrospective cohort study. Sci Rep. 2018, 8:12742. 10.1038\/s41598-018-30687-0","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-18862","article-title":"Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies","volume":"27","author":"Levi M","year":"2001","unstructured":"Levi M, de Jonge E, van der Poll T, ten Cate H. Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies. Semin Thromb Hemost. 2001, 27:569-75. 10.1055\/s-2001-18862","journal-title":"Semin Thromb Hemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2019.62.5.299","article-title":"Management of disseminated intravascular coagulation associated with placental abruption and measures to improve outcomes","volume":"62","author":"Takeda J","year":"2019","unstructured":"Takeda J, Takeda S. Management of disseminated intravascular coagulation associated with placental abruption and measures to improve outcomes. Obstet Gynecol Sci. 2019, 62:299-306. 10.5468\/ogs.2019.62.5.299","journal-title":"Obstet Gynecol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1585424","article-title":"The impact of the abruption severity and the onset-to-delivery time on the maternal and neonatal outcomes of placental abruption","volume":"33","author":"Onishi K","year":"2020","unstructured":"Onishi K, Tsuda H, Fuma K, Kuribayashi M, Tezuka A, Ando T, Mizuno K. The impact of the abruption severity and the onset-to-delivery time on the maternal and neonatal outcomes of placental abruption. J Matern Fetal Neonatal Med. 2020, 33:3775-83. 10.1080\/14767058.2019.1585424","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2019.1675625","article-title":"Clinical analysis and classification of placental abruption","volume":"34","author":"Qiu Y","year":"2021","unstructured":"Qiu Y, Wu L, Xiao Y, Zhang X. Clinical analysis and classification of placental abruption. J Matern Fetal Neonatal Med. 2021, 34:2952-6. 10.1080\/14767058.2019.1675625","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2009.04.002","article-title":"Disseminated intravascular coagulation in obstetric disorders and its acute haematological management","volume":"23","author":"Thachil J","year":"2009","unstructured":"Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 2009, 23:167-76. 10.1016\/j.blre.2009.04.002","journal-title":"Blood Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00003081-198528010-00004","article-title":"Intrauterine fetal demise and hemostatic failure: The fetal death syndrome","volume":"28","author":"Romero R","year":"1985","unstructured":"Romero R, Copel JA, Hobbins JC. Intrauterine fetal demise and hemostatic failure: The fetal death syndrome. Clin Obstet Gynecol. 1985, 28:24-31. 10.1097\/00003081-198528010-00004","journal-title":"Clin Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270495","article-title":"Critical factors associated with postpartum maternal death in Ethiopia","volume":"17","author":"Tesfay N","year":"2022","unstructured":"Tesfay N, Tariku R, Zenebe A, Woldeyohannes F. Critical factors associated with postpartum maternal death in Ethiopia. PLoS One. 2022, 17:e0270495. 10.1371\/journal.pone.0270495","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2020-0013","article-title":"Time trends of the outcomes and treatment options for disseminated intravascular coagulation: A nationwide observational study in Japan","volume":"3","author":"Yamakawa K","year":"2020","unstructured":"Yamakawa K, Ohbe H, Taniguchi K, Matsui H, Fushimi K, Yasunaga H. Time trends of the outcomes and treatment options for disseminated intravascular coagulation: A nationwide observational study in Japan. JMA J. 2020, 3:313-20. 10.31662\/jmaj.2020-0013","journal-title":"JMA J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(17)30428-x","article-title":"Updated WHO recommendation on intravenous tranexamic acid for the treatment of post-partum haemorrhage","volume":"6","author":"Vogel JP","year":"2018","unstructured":"Vogel JP, Oladapo OT, Dowswell T, G\u00fclmezoglu AM. Updated WHO recommendation on intravenous tranexamic acid for the treatment of post-partum haemorrhage. Lancet Glob Health. 2018, 6:18-9. 10.1016\/s2214-109x(17)30428-x","journal-title":"Lancet Glob Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.16938","article-title":"Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: A nationwide observational study in Japan","volume":"129","author":"Iwasaki Y","year":"2022","unstructured":"Iwasaki Y, Ohbe H, Shigemi D, Fushimi K, Yasunaga H. Effect of antithrombin III among patients with disseminated intravascular coagulation in obstetrics: A nationwide observational study in Japan. Bjog. 2022, 129:805-11. 10.1111\/1471-0528.16938","journal-title":"Bjog"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618806424","article-title":"Disseminated intravascular coagulation: An update on pathogenesis, diagnosis, and therapeutic strategies","volume":"24","author":"Papageorgiou C","year":"2018","unstructured":"Papageorgiou C, Jourdi G, Adjambri E, et al.. Disseminated intravascular coagulation: An update on pathogenesis, diagnosis, and therapeutic strategies. Clin Appl Thromb Hemost. 2018, 24:8S-28S. 10.1177\/1076029618806424","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2014.00187","article-title":"Firth logistic regression for rare variant association tests","volume":"5","author":"Wang X","year":"2014","unstructured":"Wang X. Firth logistic regression for rare variant association tests. Front Genet. 2014, 5:187. 10.3389\/fgene.2014.00187","journal-title":"Front Genet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-023-01511-8","article-title":"Prenatal hypertension as the risk of eclampsia, HELLP syndrome, and critical obstetric hemorrhage","volume":"47","author":"Akaishi T","year":"2024","unstructured":"Akaishi T, Tarasawa K, Hamada H, et al.. Prenatal hypertension as the risk of eclampsia, HELLP syndrome, and critical obstetric hemorrhage. Hypertens Res. 2024, 47:455-66. 10.1038\/s41440-023-01511-8","journal-title":"Hypertens Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.22074\/cellj.2019.5992","article-title":"Why, when and how to adjust your P values?","volume":"20","author":"Jafari M","year":"2019","unstructured":"Jafari M, Ansari-Pour N. Why, when and how to adjust your P values?. Cell J. 2019, 20:604-7. 10.22074\/cellj.2019.5992","journal-title":"Cell J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.97.155","article-title":"Heparin treatment of amniotic fluid embolism","volume":"97","author":"Maki M","year":"1969","unstructured":"Maki M, Tachita K, Kawasaki Y, Nagasawa K. Heparin treatment of amniotic fluid embolism. Tohoku J Exp Med. 1969, 97:155-60. 10.1620\/tjem.97.155","journal-title":"Tohoku J Exp Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(03)00630-6","article-title":"Presumed antepartum amniotic fluid embolism","volume":"102","author":"Kent KJ","year":"2003","unstructured":"Kent KJ, Cooper BC, Thomas KW, Zlatnik FJ. Presumed antepartum amniotic fluid embolism. Obstet Gynecol. 2003, 102:493-5. 10.1016\/s0029-7844(03)00630-6","journal-title":"Obstet Gynecol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s40981-015-0001-x","article-title":"Successful resuscitation of amniotic fluid embolism applying a new classification and management strategy","volume":"1","author":"Yufune S","year":"2015","unstructured":"Yufune S, Tanaka M, Akai R, et al.. Successful resuscitation of amniotic fluid embolism applying a new classification and management strategy. JA Clin Rep. 2015, 1:1. 10.1186\/s40981-015-0001-x","journal-title":"JA Clin Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58010111","article-title":"Incidence of emergency peripartum hysterectomy in a tertiary obstetrics unit in Romania","volume":"58","author":"Gic\u0103 N","year":"2022","unstructured":"Gic\u0103 N, Ragea C, Botezatu R, Peltecu G, Gic\u0103 C, Panaitescu AM. Incidence of emergency peripartum hysterectomy in a tertiary obstetrics unit in Romania. Medicina (Kaunas). 2022, 58:111. 10.3390\/medicina58010111","journal-title":"Medicina (Kaunas)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.50661","article-title":"Risk factors associated with peripartum suicide attempts in Japan","volume":"6","author":"Akaishi T","year":"2023","unstructured":"Akaishi T, Tarasawa K, Fushimi K, et al.. Risk factors associated with peripartum suicide attempts in Japan. JAMA Netw Open. 2023, 6:e2250661. 10.1001\/jamanetworkopen.2022.50661","journal-title":"JAMA Netw Open"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(86)90109-8","article-title":"Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions","volume":"8","author":"Ekre HP","year":"1986","unstructured":"Ekre HP, Fjellner B, H\u00e4germark O. Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions. Int J Immunopharmacol. 1986, 8:277-86. 10.1016\/0192-0561(86)90109-8","journal-title":"Int J Immunopharmacol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-03030-5","article-title":"Diversity of disseminated intravascular coagulation and selection of appropriate treatments","volume":"113","author":"Asakura H","year":"2021","unstructured":"Asakura H. Diversity of disseminated intravascular coagulation and selection of appropriate treatments. Int J Hematol. 2021, 113:10-4. 10.1007\/s12185-020-03030-5","journal-title":"Int J Hematol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e19811","article-title":"Application of nafamostat mesylate for anticoagulation in hemoperfusion therapy in patients with bromadiolone poisoning: Case reports","volume":"9","author":"Qian W","year":"2023","unstructured":"Qian W, He C, Ren Y, Xian X, Jiang Z, Xu S. Application of nafamostat mesylate for anticoagulation in hemoperfusion therapy in patients with bromadiolone poisoning: Case reports. Heliyon. 2023, 9:e19811. 10.1016\/j.heliyon.2023.e19811","journal-title":"Heliyon"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2020.01.001","article-title":"Thrombomodulin induces anti-inflammatory effects by inhibiting the rolling adhesion of leukocytes in\u00a0vivo","volume":"143","author":"Nishizawa S","year":"2020","unstructured":"Nishizawa S, Kikuta J, Seno S, et al.. Thrombomodulin induces anti-inflammatory effects by inhibiting the rolling adhesion of leukocytes in\u00a0vivo. J Pharmacol Sci. 2020, 143:17-22. 10.1016\/j.jphs.2020.01.001","journal-title":"J Pharmacol Sci"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-1086-3","article-title":"The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study","volume":"19","author":"Yoshihara M","year":"2015","unstructured":"Yoshihara M, Uno K, Tano S, et al.. The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study. Crit Care. 2015, 19:369. 10.1186\/s13054-015-1086-3","journal-title":"Crit Care"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.575890","article-title":"Thrombomodulin as a physiological modulator of intravascular injury","volume":"11","author":"Watanabe-Kusunoki K","year":"2020","unstructured":"Watanabe-Kusunoki K, Nakazawa D, Ishizu A, Atsumi T. Thrombomodulin as a physiological modulator of intravascular injury. Front Immunol. 2020, 11:575890. 10.3389\/fimmu.2020.575890","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007557.pub3","article-title":"Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients","volume":"4","author":"Junqueira DR","year":"2017","unstructured":"Junqueira DR, Zorzela LM, Perini E. Unfractionated heparin versus low molecular weight heparins for avoiding heparin-induced thrombocytopenia in postoperative patients. Cochrane Database Syst Rev. 2017, 4:CD007557. 10.1002\/14651858.CD007557.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","unstructured":"WOMAN Trial Collaborators . Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): An international, randomised, double-blind, placebo-controlled trial. Lancet. 2017, 389:2105-16. 10.1016\/S0140-6736(17)30638-4","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1038\/srep46749","article-title":"The clinical efficacy of fibrinogen concentrate in massive obstetric haemorrhage with hypofibrinogenaemia","volume":"7","author":"Matsunaga S","year":"2017","unstructured":"Matsunaga S, Takai Y, Nakamura E, et al.. The clinical efficacy of fibrinogen concentrate in massive obstetric haemorrhage with hypofibrinogenaemia. Sci Rep. 2017, 7:46749. 10.1038\/srep46749","journal-title":"Sci Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/252853-risk-assessment-of-critical-obstetric-bleeding-with-low-molecular-weight-heparin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:38:59Z","timestamp":1715233139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/252853-risk-assessment-of-critical-obstetric-bleeding-with-low-molecular-weight-heparin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.59933","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,8]]}}}